Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.88-22.9339.0023.66644.34

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -4.88 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹343.7 Cr 30.6% 29.7% 93.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

30.6%

29.7%

93.5%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses